Crispr babies vs 'bubble boy'

In assessing the risks of human experimentation, the key guiding point has still to be the patient's welfare

The news that scientists may have finally used gene therapy to cure the "bubble boy" immune disorder, SCID-X1, came as a surprise not because it happened so fast, but because it took so long that it had begun to seem impossible.

Scientists were talking about revolutionising medicine with gene therapy back in the 1980s, and the first child with a different form of the disease, called SCID-ADA, was given gene therapy in 1992.

Please or to continue reading the full article. Learn more about ST PREMIUM.

Enjoy unlimited access to ST's best work

  • Exclusive stories and features on multiple devices
  • In-depth analyses and opinion pieces
  • ePaper and award-winning multimedia content
A version of this article appeared in the print edition of The Straits Times on May 02, 2019, with the headline 'Crispr babies vs 'bubble boy''. Print Edition | Subscribe